Search Orphan Drug Designations and Approvals
-
| Generic Name: | IL-8 receptor-modified CD70-specific CAR T cells |
|---|---|
| Date Designated: | 05/13/2026 |
| Orphan Designation: | treatment of malignant glioma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Immunogenik, Inc. 747 SW 2nd Ave Suite 321, Box 67 Gainesville, Florida 32601 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







